检索结果 - Yasuo Hamamoto
- Showing 1 - 20 results of 22
- Go to Next Page
-
1
-
2
-
3
Randomized phase <scp>II</scp> study of gemcitabine plus <scp>S</scp>‐1 versus <scp>S</scp>‐1 in advanced biliary tract cancer: A <scp>J</scp>apan <scp>C</scp>linical <scp>O</scp>n... 由 Chigusa Morizane, Takuji Okusaka, Junki Mizusawa, Atsuo Takashima, Makoto Ueno, Masafumi Ikeda, Yasuo Hamamoto, Hiroshi Ishii, Narikazu Boku, Junji Furuse
出版 2013Artigo -
4
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma 由 Hiroki Hara, Makoto Tahara, Hiroyuki Daiko, Ken Kato, Hiroyasu Igaki, Shigenori Kadowaki, Yoïchi Tanaka, Yasuo Hamamoto, Hisayuki Matsushita, Michitaka Nagase, Yoshinori Hosoya
出版 2013Artigo -
5
Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors 由 Keitaro Shimozaki, Hideyuki Hayashi, Shigeki Tanishima, Sara Horie, Akihiko Chida, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Eriko Aimono, Kenro Hirata, Hiroshi Nishihara, Takanori Kanai∥, Yasuo Hamamoto
出版 2021Artigo -
6
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with... 由 Tomohiro Nishina, Narikazu Boku, Masahiro Gotoh, Yasuhiro Shimada, Yasuo Hamamoto, Hirofumi Yasui, Kensei Yamaguchi, H. Kawai, Norisuke Nakayama, Kenji Amagai, Junki Mizusawa, Kenichi Nakamura, Kuniaki Shirao, Atsushi Ohtsu
出版 2015Artigo -
7
Mesenchymal stem cells regulate epithelial–mesenchymal transition and tumor progression of pancreatic cancer cells 由 Ayano Kabashima‐Niibe, Hajime Higuchi, Hiromasa Takaishi, Yohei Masugi, Yumi Matsuzaki, Yo Mabuchi, Shinsuke Funakoshi, Masayuki Adachi, Yasuo Hamamoto, Shigeyuki Kawachi, Koichi Aiura, Yuko Kitagawa, Michiie Sakamoto, Toshifumi Hibi∥
出版 2012Artigo -
8
-
9
Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells 由 Hideko Akagi, Hajime Higuchi, Hidetoshi Sumimoto, Toru Igarashi, Ayano Kabashima, Hiroyuki Mizuguchi, Motoko Izumiya, Gen Sakai, Masayuki Adachi, Shinsuke Funakoshi, Shoko Nakamura, Yasuo Hamamoto, Takanori Kanai∥, Hiromasa Takaishi, Yutaka Kawakami, Toshifumi Hibi∥
出版 2012Artigo -
10
Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer 由 Shuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, Tatsuo Matsuda, Tomonobu Fujita, Hajime Higuchi, Junichi Taguchi, Hiroya Takeuchi, Osamu Itano, Koichi Aiura, Yasuo Hamamoto, Hiromasa Takaishi, Masato Okamoto, Makoto Sunamura, Yutaka Kawakami, Yuko Kitagawa
出版 2015Artigo -
11
Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (J... 由 Kuniaki Shirao, Narikazu Boku, Yasuhide Yamada, Kensei Yamaguchi, Toshihiko Doi, Masanori Goto, Junichiro Nasu, Tadamichi Denda, Yasuo Hamamoto, Atsuo Takashima, Haruhiko Fukuda, Atsushi Ohtsu, Akira Sawaki, Hogara Nishisaki, Kenji Amagai, Yusuke Suzuki
出版 2013Artigo -
12
<p>Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors</p> 由 Keitaro Shimozaki, Yasutaka Sukawa, Noriko Beppu, Isao Kurihara, Shigeaki Suzuki, Ryuichi Mizuno, Takeru Funakoshi, Shinnosuke Ikemura, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Kenro Hirata, Hideyuki Hayashi, Yasuo Hamamoto, Hiromasa Takaishi, Takanori Kanai∥
出版 2020Artigo -
13
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToG... 由 Akira Sawaki, Yasuo Ohashi, Yasushi Omuro, Taroh Satoh, Yasuo Hamamoto, Narikazu Boku, Yoshinori Miyata, Hiroya Takiuchi, Kensei Yamaguchi, Yasutsuna Sasaki, Tomohiro Nishina, Atsushi Satoh, Eishi Baba, Takao Tamura, Takashi Abe, Kiyohiko Hatake, Atsushi Ohtsu
出版 2011Artigo -
14
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (AT... 由 Masanobu Takahashi, Ken Kato, Morihito Okada, Keisho Chìn, Shigenori Kadowaki, Yasuo Hamamoto, Yuichiro� Doki, Yutaro Kubota, Hisato Kawakami, Takashi Ogata, Hiroki Hara, Manabu Muto, Yuichiro Nakashima, Ryu Ishihara, Masahiro Tsuda, Satoru Motoyama, Mamoru Kodani, Yuko Kitagawa
出版 2020Artigo -
15
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesopha... 由 Tomoya Yokota, Ken Kato, Yasuo Hamamoto, Yasuhiro Tsubosa, Hirofumi Ogawa, Yoshinori Ito, Hiroki Hara, Takashi Ura, Takashi Kojima, Keisho Chìn, Shuichi Hironaka, Takayuki Kii, Yasushi Kojima, Yasunori Akutsu, Hisayuki Matsushita, Kentaro Kawakami, Keita Mori, Yushi Nagai, Chika Asami, Yuko Kitagawa
出版 2016Artigo -
16
Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) 由 Morihito Okada, Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Chen‐Yuan Lin, Keisho Chìn, Shigenori Kadowaki, Myung‐Ju Ahn, Yasuo Hamamoto, Yuichiro� Doki, Chueh‐Chuan Yen, Yutaro Kubota, Sung‐Bae Kim, Chih‐Hung Hsu, Eva Holtved, Ioannis Xynos, Yasuhiro Matsumura, Akira Takazawa, Yuko Kitagawa
出版 2022Artigo -
17
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer 由 S. Ohkawa, Takuji Okusaka, Hiroyuki Isayama, Akira Fukutomi, Kensei Yamaguchi, Masafumi Ikeda, A Funakoshi, Michitaka Nagase, Yasuo Hamamoto, Shoji Nakamori, Y. Tsuchiya, Hideo Baba, Hiroshi Ishii, Yasushi Omuro, Masayuki Sho, Shigemi Matsumoto, N. Yamada, Hiroaki Yanagimoto, Michiaki Unno, Yasushi Ichikawa, Shin Takahashi, G Watanabe, Go Wakabayashi, Naoto Egawa, Masahiro Tsuda, Ryo Hosotani, Chieko Hamada, Ichinosuke Hyodo
出版 2015Artigo -
18
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivol... 由 Taroh Satoh, Yoon‐Koo Kang, Yee Chao, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, M Tanimoto, Li‐Tzong Chen, Narikazu Boku
出版 2019Artigo -
19
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data 由 Li‐Tzong Chen, Taroh Satoh, Min‐Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, Hiroki Sameshima, Yoon‐Koo Kang, Narikazu Boku
出版 2019Artigo -
20
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab 由 Narikazu Boku, Taroh Satoh, Min‐Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, Taihei Nishiyama, Li‐Tzong Chen, Yoon‐Koo Kang
出版 2021Artigo
相关主题
Medicine
Internal medicine
Cancer
Gastroenterology
Surgery
Chemotherapy
Oncology
Confidence interval
Hazard ratio
Immunotherapy
Randomized controlled trial
Nivolumab
Clinical endpoint
Pathology
Regimen
Colorectal cancer
Fluorouracil
Pancreatic cancer
Alternative medicine
Biology
Environmental health
Gemcitabine
Genetics
Placebo
Population
Immunology
Neutropenia
Phases of clinical research
Surgical oncology
Adverse effect